Skip to content
★ Sign in to follow
IT

INDOFARMA Tbk, PT Stock: price and insider trades · Indonesia

ID·Mcap IDR 390.5BHealth Care

No insider purchase over the last 90 days. The latest, by gunawan, was filed 20 Jul 2026.

INDOFARMA Tbk, PT: what insiders have been doing

We have very little insider data for INDOFARMA Tbk, PT so far: the most recent filing dates from 20 July 2026. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by OJK / IDX and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: Bekasi, Indonesia · Founded: 1918

Source: Wikidata (CC0).

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Gunawan1 buy
Fundamental score
Ranked 26,771 of 26,897 companies
4.6
score / 100
Value
7
Quality
2
FCF yld-54%
Earn yld-20%
EV/EBITDA·
ROE·
Gross mgn-13%
Net mgn-51%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

IDR 126.00
Analyst consensus
·
Income statement
RevenueIDR 151.6B
Gross profit-IDR 19.2B-13% margin
EBITDA-IDR 39.9B-26% margin
Net income-IDR 78B-41.3% margin
Valuation
Beta0.27
Balance sheet & cash
Market capIDR 390.5B
Total debtIDR 700.3B
Free Cash Flow-IDR 210B
Profitability & ownership
ROA-19.4%
% insiders88.0%
% institutions0.0%
Last declaration on 20 July 2026
Declarations1 total
  • ▲
    DireksiExecutives
    0IDX
    0IDXIDX:LK-20072026-0004-1#0
    Canonical exit: 18 Oct 2026 (T+90)

1 of 1 declaration

About INDOFARMA Tbk, PT

INDOFARMA Tbk, PT is a publicly traded company on the Indonesia Stock Exchange, specializing in the manufacturing and distribution of pharmaceutical products. It focuses on improving public health by providing quality medications.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations